Paramagnetic Signals in the Globus Pallidus as Late Radiographic Sign of Juvenile-Onset GM1 Gangliosidosis

被引:9
|
作者
Takenouchi, Toshiki [1 ]
Kosaki, Rika [2 ]
Nakabayashi, Kazuhiko [3 ]
Hata, Kenichiro [3 ]
Takahashi, Takao [1 ]
Kosaki, Kenjiro [4 ]
机构
[1] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan
[2] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan
[3] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan
[4] Keio Univ, Sch Med, Ctr Genet Med, Tokyo 1608582, Japan
关键词
GM1; gangliosidosis; GLB1; neurodegeneration with brain iron accumulation; next-generation sequencing;
D O I
10.1016/j.pediatrneurol.2014.09.022
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: The juvenile form of GM1 gangliosidosis lacks specific physical findings and thus is often a diagnostic challenge for clinicians. T-2 hypodensity in the globus pallidus is a characteristic radiographic sign of neurodegeneration with iron accumulation in the brain that is observed in GM1 gangliosidosis, but the exact timing when this radiographic sign becomes apparent remains to be elucidated. PATIENTS: Two male siblings had normal development until 2 years of age and then developed psychomotor regression with dystonia. Their neuroimaging studies indicated progressive global cerebral atrophy. Exome sequencing identified compound heterozygous missense mutations in GLB1, leading to a diagnosis of GM1 gangliosidosis. RESULTS: A retrospective review of neuroimaging studies revealed that the two patients had strikingly similar clinical courses and radiographic progressions with cortical atrophy that preceded the T-2 hypointensity in the globus pallidus. CONCLUSIONS: Paramagnetic signals in the globus pallidus become apparent relatively late during the disease course, once cerebral atrophy has already become prominent. A comprehensive diagnostic approach involving clinical, radiographic, and genetic testing is necessary for the early identification of affected individuals.
引用
收藏
页码:226 / 229
页数:4
相关论文
共 50 条
  • [41] Generalised dystonia with an abnormal magnetic resonance imaging signal in the basal ganglia:: A case of adult-onset GM1 gangliosidosis
    Campdelacreu, J
    Muñoz, E
    Gómez, B
    Pujol, T
    Chabás, A
    Tolosa, E
    MOVEMENT DISORDERS, 2002, 17 (05) : 1095 - 1097
  • [42] Imaging in Late-Onset GM2 Gangliosidosis: A Systematic Review (P1-1.Virtual)
    Haxton, Elizabeth
    Godbole, Neha
    Rowe, Olivia
    Eichler, Florian
    Ratai, Eva-Maria
    Stephen, Christopher
    NEUROLOGY, 2022, 98 (18)
  • [43] A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO): Baseline clinical data
    Giugliani, Roberto
    Harmatz, Paul
    Heron, Benedicte
    Patterson, Marc
    Schneider, Susanne
    Bourchany, Aurelie
    Hahn, Andreas
    Valle, Daniel A. D.
    Barone, Rita Maria Elisa
    Chabrol, Brigitte
    Ardissone, Anna
    Batzios, Spyros
    Scarpa, Maurizio
    Crapard, Laetitia
    de Frutos, Laura Lopez
    Quintela, Renata Medinaceli
    Meyer, Elisa
    Thiers, Aurelien
    Luzy, Cecile Paquet
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [44] A natural history study of late-infantile and juvenile GM1 and GM2 gangliosidoses (PRONTO): Patients' and caregivers' assessments
    Giugliani, Roberto
    Harmatz, Paul
    Heron, Benedicte
    Patterson, Marc
    Schneider, Susanne
    Bourchany, Aurelie
    Hahn, Andreas
    Valle, Daniel A. D.
    Barone, Rita Maria Elisa
    Chabrol, Brigitte
    Ardissone, Anna
    Batzios, Spyros
    Scarpa, Maurizio
    Carp, Nicoleta
    Crapard, Laetitia
    de Frutos, Laura Lopez
    Quintela, Renata Medinaceli
    Thiers, Aurelien
    Luzy, Cecile Paquet
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [45] BIOCHEMICAL AND MOLECULAR ASPECTS OF LATE-ONSET GM2-GANGLIOSIDOSIS - B1 VARIANT AS A PROTOTYPE
    SUZUKI, K
    VANIER, MT
    DEVELOPMENTAL NEUROSCIENCE, 1991, 13 (4-5) : 288 - 294
  • [46] B1 variant of GM2 gangliosidosis. Pathological and biochemical study of a late onset form.
    Mikol, J
    LavergneSlove, A
    LeCoz, P
    Goutieres, F
    Vanier, MT
    BRAIN PATHOLOGY, 1997, 7 (04) : 1062 - 1062
  • [47] Intracranial Injection of AAVrh8-mβgal in a GM1 Gangliosidosis Mouse Model Delays Disease Onset and Significantly Extends Life Span
    Weismann, Cara M.
    Ferreira, Jennifer
    Maitland, Stacy
    Sena-Esteves, Miguel
    MOLECULAR THERAPY, 2013, 21 : S228 - S228
  • [48] Interim Safety, Biomarker, and Efficacy Data From Imagine-1: A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of a Single Dose, ICM Administration of PBGM01 in Subjects with Type I (Early Onset) and 10. Type IIa (Late Onset) Infantile GM1 Gangliosidosis (GM1)
    Weinstein, David A.
    Hastings, Caroline A.
    Day-Salvatore, Debra-Lynn
    Ficicioglu, Can
    Whitley, Chester B.
    Inbar-Feigenberg, Michal
    Bernard, Genevieve
    Giugliani, Roberto
    Baruteau, Julien
    Ezgu, Fatih S.
    Jarnes, Jeanine R.
    Ni, Yan G.
    Nagilla, Pruthvi
    Ballard, Victoria L.
    Haws, Thomas F.
    Gelb, Michael H.
    Forman, Mark S.
    MOLECULAR THERAPY, 2022, 30 (05) : 5 - 6
  • [49] A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism
    Keogh, Michael J.
    Daud, D.
    Pyle, A.
    Griffin, J. Duff H.
    He, L.
    Alston, C. L.
    Steele, H.
    Taggart, S.
    Basu, A. P.
    Taylor, R. W.
    Horvath, R.
    Ramesh, V.
    Chinnery, Patrick F.
    NEUROGENETICS, 2015, 16 (01) : 65 - 67
  • [50] A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism
    Michael J. Keogh
    D. Daud
    A. Pyle
    J. Duff
    H. Griffin
    L. He
    C. L. Alston
    H. Steele
    S. Taggart
    A. P. Basu
    R. W. Taylor
    R. Horvath
    V. Ramesh
    Patrick F. Chinnery
    neurogenetics, 2015, 16 : 65 - 67